Genetic Determination and Immunopathogenesis of Type 1 Diabetes Mellitus in Humans

ADA. Diagnosis and classification of diabetes mellitus. Diabetes care 2010; 33 (Suppl 1): S62-69.10.2337/dc10-S062Search in Google Scholar

Aguilera E, Casamitjana R, Ercilla, G, Oriola J, Gomis R, Conget I. Adult-onset atypical (type 1) diabetes: additional insights and differences with type 1A diabetes in a European Mediterranean population. Diabetes Care 2004; 27: 1108-1114.10.2337/diacare.27.5.1108Search in Google Scholar

Atkinson MA, Eisenbarth GS. Type 1 diabetes: new perspectives on disease pathogenesis and treatment. Lancet 2001; 358: 221-229.10.1016/S0140-6736(01)05415-0Search in Google Scholar

Todd JA, Knip M, Mathieu C. Strategies for the prevention of autoimmune type 1 diabetes. Diabet Med 2011; 28: 1141-1143.10.1111/j.1464-5491.2011.03400.x320621921812815Search in Google Scholar

Kantarova D, Buc M. Genetic susceptibility to type 1 diabetes mellitus in humans. Physiol Res 2007; 56: 255-266.10.33549/physiolres.93095616792463Search in Google Scholar

Maier LM, Wicker LS. Genetic susceptibility to type 1 diabetes. Curr Opin Immunol 2005; 17: 601-608.10.1016/j.coi.2005.09.01316226440Search in Google Scholar

Todd JA. Etiology of type 1 diabetes. Immunity 2010; 32: 457-467.10.1016/j.immuni.2010.04.00120412756Search in Google Scholar

Jahromi MM, Eisenbarth GS. Genetic determinants of type 1 diabetes across populations. Ann New York Acad Sci 2006; 1079: 289-299.10.1196/annals.1375.04417130568Search in Google Scholar

Eisenbart GS. Diabetes and related autoimmune disease. 1035-1053. In: Rich RE (ed). Clinical Immunology. Principles and Practice. 3^rd ed. Philadelphia; Elsevier, 2008.Search in Google Scholar

Concannon P, Rich SS, Nepom GT. Genetics of type 1A diabetes. New Engl J Med 2009; 360: 1646-1654.10.1056/NEJMra080828419369670Search in Google Scholar

Nepom GT. HLA and type I diabetes. In: Lechler R, Warrens A (eds): HLA in health and disease. New York, Boston, London, Sydney, Tokyo, San Diego, San Francisco: Academic Press; 2000. p. 231-237.10.1016/B978-012440315-4/50090-2Search in Google Scholar

Buc M, Bucova M, Javor J, Krivosikova M, Stuchlikova M, Shawkatova I, Michalkova D, Barak L, Jancova E, Petrek M. Associations between HLA class II alleles and type 1 diabetes mellitus in the Slovak population. Endocrine Regulations 2006; 40: 1-6.Search in Google Scholar

Concannon P, Erlich HA, Julier C, Morahan G, Nerup J, Pociot F, Todd JA, Rich SS. Type 1 diabetes: evidence for susceptibility loci from four genome-wide linkage scans in 1,435 multiplex families. Diabetes 2005; 54: 2995-3001.10.2337/diabetes.54.10.299516186404Search in Google Scholar

Ziegler AG, Nepom GT. Prediction and pathogenesis in type 1 diabetes. Immunity 2010; 32: 468-478.10.1016/j.immuni.2010.03.018286171620412757Search in Google Scholar

Noble JA, Valdes AM, Thomson G, Erlich HA. The HLA class II locus DPB1 can influence susceptibility to type 1 diabetes. Diabetes 2000; 49: 121-125.10.2337/diabetes.49.1.12110615959Search in Google Scholar

Stuchlikova M, Kantarova D, Michalkova D, Barak L, Buc M. Association of HLA-DPB1 alleles with type I diabetes mellitus in Slovak population. Bratislava Med J 2006; 107: 73-75.Search in Google Scholar

Valdes AM, Noble JA, Genin E, Clerget-Darpoux F, Erlich HA, Thomson G. Modeling of HLA class II susceptibility to Type I diabetes reveals an effect associated with DPB1. Genetic Epidemiol 2001; 21: 212-223.10.1002/gepi.103011668578Search in Google Scholar

Santamaria P. The long and winding road to understanding and conquering type 1 diabetes. Immunity 2010; 32: 437-445.10.1016/j.immuni.2010.04.00320412754Search in Google Scholar

Durinovic-Bello I, Wu RP, Gersuk VH, Sanda S, Shilling HG, Nepom GT. Insulin gene VNTR genotype associates with frequency and phenotype of the autoimmune response to proinsulin. Genes Immunity 2010; 11: 188-193.10.1038/gene.2009.108284551620054344Search in Google Scholar

Ueda H, Howson JM, Esposito L, Heward J, Snook H, Chamberlain G, Rainbow, DB, Hunter KM, Smith AN, Di Genova G. Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease. Nature 2003; 423: 506-511.10.1038/nature0162112724780Search in Google Scholar

Atabani SF, Thio CL, Divanovic S, Trompette A, Belkaid Y, Thomas D, Karp CL. Association of CTLA4 polymorphism with regulatory T cell frequency. Eur J Immunol 2005; 35: 2157-2162.10.1002/eji.20052616815940668Search in Google Scholar

Bottini N, Musumeci L, Alonso A, Rahmouni S, Nika K, Rostamkhani M, MacMurray J, Meloni GF, Lucarelli P, Pellecchia M et a. (2004) A functional variant of lymphoid tyrosine phosphatase is associated with type I diabetes. Nature Genetics 3: 337-33810.1038/ng132315004560Search in Google Scholar

Smyth D, Cooper JD, Collins JE, Heward JM, Franklyn JA, Howson JM, Vella A, Nutland S, Rance HE, Maier L. Replication of an association between the lymphoid tyrosine phosphatase locus (LYP/PTPN22) with type 1 diabetes, and evidence for its role as a general autoimmunity locus. Diabetes 2004; 53: 3020-3023.10.2337/diabetes.53.11.302015504986Search in Google Scholar

Long SA, Cerosaletti K, Bollyky PL, Tatum M, Shilling H, Zhang S, Zhang, ZY, Pihoker C, Sanda S, Greenbaum C, Buckner JH. Defects in IL-2R signaling contribute to diminished maintenance of FOXP3 expression in CD4(+)CD25(+) regulatory T-cells of type 1 diabetic subjects. Diabetes 2010; 59: 407-415.10.2337/db09-0694280997019875613Search in Google Scholar

Vella A, Cooper JD, Lowe CE, Walker N, Nutland S, Widmer B, Jones R, Ring, SM, McArdle W, Pembrey ME. Localization of a type 1 diabetes locus in the IL2RA/CD25 region by use of tag single-nucleotide polymorphisms. Am J Human Genet 2005; 76: 773-779.10.1086/429843119936715776395Search in Google Scholar

Dendrou CA, Plagnol V, Fung E, Yang JH, Downes K, Cooper JD, Nutland S, Coleman G, Himsworth M, Hardy M. Cell-specific protein phenotypes for the autoimmune locus IL2RA using a genotype-selectable human bioresource. Nature Genet 209; 41: 1011-1015.10.1038/ng.434274950619701192Search in Google Scholar

Dendrou CA, Wicker LS. The IL-2/CD25 pathway determines susceptibility to T1D in humans and NOD mice. J Clin Immunol 2008; 28: 685-696.10.1007/s10875-008-9237-918780166Search in Google Scholar

Sakaguchi S, Miyara M, Costantino CM, Hafler DA. FOXP3+ regulatory T cells in the human immune system. Nature Rev Immunol 2010; 10: 490-500.10.1038/nri278520559327Search in Google Scholar

Sandor F, Buc M. Toll-like receptors. I. Structure, function and their ligands. Folia Biol 2005; 51: 148-157.Search in Google Scholar

Svoren BM, Volkening LK, Wood JR, Laffel LM. Significant vitamin D deficiency in youth with type 1 diabetes mellitus. J Pediatrics 2009; 154: 132-134.10.1016/j.jpeds.2008.07.015263594119187735Search in Google Scholar

Winkler C, Lauber C, Adler K, Grallert H, Illig T, Ziegler AG, Bonifacio E. An interferon-induced helicase (IFIH1) gene polymorphism associates with different rates of progression from autoimmunity to type 1 diabetes. Diabetes 2011; 60: 685-690.10.2337/db10-1269302837121270278Search in Google Scholar

Witso E, Tapia G, Cinek O, Pociot FM, Stene LC, Ronningen KS. Polymorphisms in the innate immune IFIH1 gene, frequency of enterovirus in monthly fecal samples during infancy, and islet autoimmunity. PloS One 2011; 6: e27781.10.1371/journal.pone.0027781321573922110759Search in Google Scholar

Salminen K, Sadeharju, K, Lonnrot M, Vahasalo P, Kupila A, Korhonen S, Ilonen J, Simell O, Knip M, Hyoty H. Enterovirus infections are associated with the induction of beta-cell autoimmunity in a prospective birth cohort study. J Med Virol 2003; 69: 91-98.10.1002/jmv.1026012436483Search in Google Scholar

Yoon JW, Austin M, Onodera T, Notkins AL. Isolation of a virus from the pancreas of a child with diabetic ketoacidosis. The New England journal of medicine 1979; 300: 1173-1179.10.1056/NEJM197905243002102219345Search in Google Scholar

Kukreja A, Maclaren NK. Autoimmunity and diabetes. J Clin Endocrinol Metabolism 1999; 84: 4371-4378.10.1210/jcem.84.12.621210599690Search in Google Scholar

Heino L, Lonnrot M, Knip M, Kupila A, Erkkila S, Toivonen A, Vahasalo P, Ilonen, J, Simell O, Hyoty H. No evidence of abnormal regulation of antibody response to coxsackievirus B4 antigen in prediabetic children. Clin Exp Immunol 2001; 126: 432-436.10.1111/j.1365-2249.2001.01691.x190622011737058Search in Google Scholar

Horwitz MS, Bradley LM, Harbertson J, Krahl T, Lee J, Sarvetnick N. Diabetes induced by Coxsackie virus: initiation by bystander damage and not molecular mimicry. Nature Med 1998; 4: 781-785.10.1038/nm0798-7819662368Search in Google Scholar

Hoe E, McKay FC, Schibeci SD, Gandhi K, Heard RN, Stewart GJ, Booth DR. Functionally significant differences in expression of disease-associated IL-7 receptor alpha haplotypes in CD4 T cells and dendritic cells. J Immunol 2010; 184: 2512-2517.10.4049/jimmunol.090290020097866Search in Google Scholar

Smyth DJ, Plagnol V, Walker NM, Cooper JD, Downes, K, Yang JH, Howson JM, Stevens H, McManus R, Wijmenga C. Shared and distinct genetic variants in type 1 diabetes and celiac disease. New Engl J Med 2008; 359: 2767-2777.10.1056/NEJMoa0807917284083519073967Search in Google Scholar

Abbas AK, Lichtman AH, Pillai S. Cellular and Molecular Immunology. Philadelphia; 7. Saunders, Elsevier, 2012: 545.Search in Google Scholar

Buc M. Basic and Clinical immunology. Bratislava; Veda, 2012, in press (in Slovak).Search in Google Scholar

Stadinski B, Kappler J, Eisenbarth GS. Molecular targeting of islet autoantigens. Immunity 2010; 32: 446-456.10.1016/j.immuni.2010.04.00820412755Search in Google Scholar

Achenbach P, Bonifacio E, Ziegler AG. Predicting type 1 diabetes. Curr Diabetes Rep 2005; 5: 98-103.10.1007/s11892-005-0035-y15794911Search in Google Scholar

Haskins K, Bradley B, Powers K, Fadok V, Flores S, Ling X. Pugazhenthi S, Reusch, J, Kench J. Oxidative stress in type 1 diabetes. Ann New York Acad Sci 2003; 1005: 43-54.10.1196/annals.1288.00614679039Search in Google Scholar

Kent SC, Chen Y, Bregoli L, Clemmings SM, Kenyon NS, Ricordi C, Hering BJ, Hafler DA. Expanded T cells from pancreatic lymph nodes of type 1 diabetic subjects recognize an insulin epitope. Nature 2005; 435: 224-228.10.1038/nature0362515889096Search in Google Scholar

Anderson MS, Bluestone JA. The NOD mouse: a model of immune dysregulation. Annu Rev Immunol 2005;23: 447-485.10.1146/annurev.immunol.23.021704.11564315771578Search in Google Scholar

Miyazaki A, Hanafusa T, Yamada K, Miyagawa J, Fujino-Kurihara H, Nakajima H, Nonaka K, Tarui S. Predominance of T lymphocytes in pancreatic islets and spleen of pre-diabetic non-obese diabetic (NOD) mice: a longitudinal study. Clin Exp Immunol 1985; 60: 622-630.Search in Google Scholar

Christianson SW, Shultz LD, Leiter EH. Adoptive transfer of diabetes into immunodeficient NOD-scid/scid mice. Relative contributions of CD4+ and CD8+ T-cells from diabetic versus prediabetic NOD.NON-Thy-1a donors. Diabetes 1993; 42: 44-55.10.2337/diab.42.1.448093606Search in Google Scholar

Like AA, Biron CA, Weringer EJ, Byman K, Sroczynski E, Guberski DL. Prevention of diabetes in BioBreeding/Worcester rats with monoclonal antibodies that recognize T lymphocytes or natural killer cells. J Exp Med 1986; 164, 1145-1159.10.1084/jem.164.4.114521884033531381Search in Google Scholar

Groen H, Klatter F, Pater J, Nieuwenhuis P, Rozing J. Temporary, but essential requirement of CD8+ T cells early in the pathogenesis of diabetes in BB rats as revealed by thymectomy and CD8 depletion. Clin Develop Immunol 2003; 10: 141-151.10.1080/10446670310001626508248540714768945Search in Google Scholar

Wu Q, Salomon B, Chen M, Wang Y, Hoffman LM, Bluestone J.A, Fu YX. Reversal of spontaneous autoimmune insulitis in nonobese diabetic mice by soluble lymphotoxin receptor. J Exp Med 2001; 193: 1327-1332.10.1084/jem.193.11.1327219338311390440Search in Google Scholar

Gommerman JL, Browning JL. Lymphotoxin/light, lymphoid microenvironments and autoimmune disease. Nature Rev Immunol 2003; 3: 642-655.10.1038/nri115112974479Search in Google Scholar

Valdes AM, Thomson G, Barcellos LF. Genetic variation within the HLA class III influences T1D susceptibility conferred by high-risk HLA haplotypes. Genes Immunity 2010; 11: 209-218.10.1038/gene.2009.104285824220054343Search in Google Scholar

Link M, Salur L, Kisand K, Rajasalu T, Tillmann V, Uibo R. Higher FoxP3 mRNA expression in peripheral blood mononuclear cells of GAD65 or IA-2 autoantibody-positive compared with autoantibody-negative persons. Apmis 2008; 116: 896-902.10.1111/j.1600-0463.2008.00889.x19132983Search in Google Scholar

Luczynski W, Stasiak-Barmuta A, Urban R, Urban M, Florys B, Hryszko M. Lower percentages of T regulatory cells in children with type 1 diabetes - preliminary report. Pediatric Endocrinol, Diabetes Metabolism 2009; 15: 34-38.Search in Google Scholar

Vrabelova Z, Hrotekova Z, Hladikova Z, Bohmova K, Stechova K, Michalek J. CD 127- and FoxP3+ expression on CD25+CD4+ T regulatory cells upon specific diabetogeneic stimulation in high-risk relatives of type 1 diabetes mellitus patients. Scand J Immunol 2008; 67: 404-410.10.1111/j.1365-3083.2008.02074.x18248531Search in Google Scholar

Long SA, Walker MR, Rieck M, James E, Kwok WW, Sanda S, Pihoker C, Greenbaum C, Nepom GT, Buckner JH. Functional islet-specific Treg can be generated from CD4+CD25- T cells of healthy and type 1 diabetic subjects. Eur J Immunol 2009; 39: 612-620.10.1002/eji.200838819274309619180473Search in Google Scholar

Putnam AL, Brusko TM, Lee MR, Liu W, Szot GL, Ghosh T, Atkinson MA, Bluestone JA. Expansion of human regulatory T-cells from patients with type 1 diabetes. Diabetes 2009; 58: 652-662.10.2337/db08-1168264606419074986Search in Google Scholar

Schneider A, Rieck M, Sanda S, Pihoker C, Greenbaum C, Buckner JH. The effector T cells of diabetic subjects are resistant to regulation via CD4+ FOXP3+ regulatory T cells. J Immunol 2008; 181: 7350-7355.10.4049/jimmunol.181.10.7350259707918981158Search in Google Scholar

Ferencik M, Stvrtinova V, Hulin I, Novak M. Inflammation - a lifelong companion. Attempt at a non-analytical holistic view. Folia Microbiol 2007; 52: 159-173.10.1007/BF02932155Search in Google Scholar

Robles DT, Eisenbarth GS. Diabetes and related autoimmune diseases. In: Rich RR (ed.) Clinical Immunology, Principles and Practice, 2nd edn. London, Edinburg, New York, Philadelphia, St. Louis, Sydney, Toronto; Mosby, 2001. p. 82. 1-82. 8.Search in Google Scholar

Luo X, Herold KC, Miller SD. Immunotherapy of type 1 diabetes: where are we and where should we be going? Immunity 2010; 32: 488-499.10.1016/j.immuni.2010.04.002286087820412759Search in Google Scholar

Flodstrom M, Maday A, Balakrishna D, Cleary MM, Yoshimura A, Sarvetnick N. Target cell defense prevents the development of diabetes after viral infection. Nature Immunol 2002; 3: 373-382.10.1038/ni77111919579Search in Google Scholar

Kukreja A, Costi G, Marker J, Zhang CH, Sinha S, Sun Z, Maclaren N. NKT cell defects in NOD mice suggest therapeutic opportunities. J Autoimmunity 2002; 19: 117-128.10.1006/jaut.2002.060912419282Search in Google Scholar

Oikawa Y, Shimada A, Yamada S, Motohash, Y, Nakagawa Y, Irie J, Maruyama T, Saruta T. High frequency of valpha24(+) vbeta11(+) T-cells observed in type 1 diabetes. Diabetes Care 2002; 25: 1818-1823.10.2337/diacare.25.10.181812351484Search in Google Scholar

Diana J, Gahzarian L, Simoni Y, Lehuen A. Innate immunity in type 1 diabetes. Discovery Med 2011; 11: 513-520.Search in Google Scholar

Serreze DV, Chapman HD, Varnum DS, Hanson MS, Reifsnyder PC, Richard SD, Fleming SA, Leiter EH, Shultz LD. B lymphocytes are essential for the initiation of T cell-mediated autoimmune diabetes: analysis of a new "speed congenic" stock of NOD. Ig mu null mice. J Exp Med 1996; 184: 2049-2053.10.1084/jem.184.5.204921928928920894Search in Google Scholar

Pescovitz MD, Greenbaum CJ, Krause-Steinrauf H, Becker DJ, Gitelman SE, Goland, R, Gottlieb PA, Marks JB, McGee PF, Moran AM. Rituximab, B-lymphocyte depletion, and preservation of beta-cell function. New Engl J Med 2009; 361: 2143-2152.10.1056/NEJMoa0904452641035719940299Search in Google Scholar

Hu CY, Rodriguez-Pinto D, Du W, Ahuja A, Henegariu O, Wong FS, Shlomchik, MJ, Wen L. Treatment with CD20-specific antibody prevents and reverses autoimmune diabetes in mice. J Clin Inv 2007; 117: 3857-3867.10.1172/JCI32405209645618060033Search in Google Scholar

Bingley PJ, Gale EA. Progression to type 1 diabetes in islet cell antibody-positive relatives in the European Nicotinamide Diabetes Intervention Trial: the role of additional immune, genetic and metabolic markers of risk. Diabetologia 2006; 49: 881-890.10.1007/s00125-006-0160-416514546Search in Google Scholar

Hummel M, Bonifacio E, Schmid S, Walter M, Knopff A, Ziegler AG. Brief communication: early appearance of islet autoantibodies predicts childhood type 1 diabetes in offspring of diabetic parents. Ann Int Med 2004; 140:882-886.10.7326/0003-4819-140-11-200406010-0000915172902Search in Google Scholar

Hanzu F, Gomis R. Autoimmune diabetes mellitus. In: Shoenfeld Y, Cervera R, Gerschwin ME (eds) Diagnostic criteria in autoimmune diseases. Totowa; Hamana Press, 2008. p. 241-249.10.1007/978-1-60327-285-8_46Search in Google Scholar

Wenzlau JM, Juhl K, Yu L, Moua O, Sarkar SA, Gottlieb P, Rewers M, Eisenbarth, GS, Jensen J, Davidson HW, Hutton JC. The cation efflux transporter ZnT8 (Slc30A8) is a major autoantigen in human type 1 diabetes. Proc Nat Acad Sci USA 2007; 104: 17040-17045.10.1073/pnas.0705894104204040717942684Search in Google Scholar